Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results.
Abbas Ali QayyumAnders Bruun MathiasenSteffen HelqvistErik JørgensenMandana Haack-SørensenAnnette EkblondJens KastrupPublished in: Journal of translational medicine (2019)
Patients receiving ASCs had improved cardiac symptoms and unchanged exercise capacity, in opposition to deterioration in the placebo group. Trial registration ClinicalTrials.gov Identifier: NCT01449032. Registered 7 October 2011-Retrospectively registered, https://www.clinicaltrials.gov/ct2/show/NCT01449032?term=jens+kastrup&rank=7.
Keyphrases
- phase iii
- study protocol
- cell therapy
- bone marrow
- clinical trial
- phase ii
- open label
- single cell
- coronary artery disease
- computed tomography
- coronary artery
- double blind
- physical activity
- preterm infants
- left ventricular
- randomized controlled trial
- image quality
- percutaneous coronary intervention
- placebo controlled
- magnetic resonance
- mesenchymal stem cells
- magnetic resonance imaging
- heart failure
- stem cells
- combination therapy
- body composition
- replacement therapy